To further assess the role and the prognostic value of SPRED2 expression for the clinical outcome in BC patients, a survival analysis was conducted using the Kaplan–Meier plotter and the Gene expression-based Outcome for Breast cancer Online (GOBO) tool [51,52]. Here, SPRED2 is linked to breast carcinoma.